DNA - Financial Reports List - Ginkgo Bioworks Holdings, Inc. - IntrinsicAlpha

Ginkgo Bioworks Holdings, Inc. DNA

Healthcare - Biotechnology - NYSE - US

$ 7.34

-6.5 %

$ 426 M

Market Cap

-0.7

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	26.16%	49.20%	32.92%
Annual Report	FY	10-K	2024-12-31	-9.71%	38.73%	35.24%
Quarterly Report	Q3	8-K	2024-09-30	60.65%	81.38%	80.72%
Quarterly Report	Q2	8-K	2024-06-30	-30.24%	-25.31%	-21.07%
Quarterly Report	Q1	8-K	2024-03-31	-52.98%	19.06%	26.42%
Quarterly Report	Q4	8-K	2023-12-31	-64.64%	-19.91%	34.14%
Annual Report	FY	10-K	2023-12-31	-47.36%	57.58%	60.87%
Quarterly Report	Q3	8-K	2023-09-30	-16.52%	54.80%	56.14%
Quarterly Report	Q2	8-K	2023-06-30	-44.29%	74.09%	71.53%
Quarterly Report	Q1	8-K	2023-03-31	-52.08%	65.29%	68.01%

1